Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2945 (LINC02945) is a human gene classified as a long non-coding RNA (lncRNA), meaning it does not encode a protein but instead may play regulatory roles in gene expression. It is listed in genome databases such as HGNC (HGNC:55960), Ensembl (ENSG00000249815), and NCBI Gene (123464519), and is also known by the alias AC004704.1[3][5][7][8][9][10]. There is currently no direct evidence that LINC02945 functions as a receptor, enzyme, transporter, or other canonical therapeutic drug target, nor are there drugs known to interact specifically with this lncRNA[10][11]. While long intergenic non-coding RNAs (lincRNAs) as a general class have been implicated in the regulation of gene expression, chromatin modification, and disease processes such as cancer, the specific biological function and clinical relevance of LINC02945 itself remains uncharacterized in available resources[10][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2945 (LINC02945).